Medical Devices and Consumables Market Analysis 2026

Medical Devices & Consumables Market Overview

In 2023 and 2024, the medical devices and consumables market has exhibited dynamic trends and robust growth, which have been influenced by a rising prevalence of chronic diseases, increased healthcare expenditure, and technological advancements. According to cognitive market research, the global medical devices market size was USD 530 billion in 2023 and it was USD 570 billion in 2024 with a compound annual growth rate (CAGR) of 7.5%. The consumables segment, which includes items like syringes, catheters, and dressings, is experience comparable growth, increasing from market size of USD 50 billion in 2023 to USD 54 billion in 2024. 

Another critical factor that stimulates market expansion is the aging of the global populace. The demand for devices such as orthopedic implants, cardiovascular devices, and mobility aids has increased due to the growing number of elderly individuals who require medical attention. The orthopedic devices market size wasUSD 45 billion in 2023 and it was USD 48 billion by 2024. Furthermore, the cardiovascular devices market, which encompasses defibrillators, stents, and pacemakers, was valued at USD 55 billion in 2023 and it was USD 59 billion in 2024. Particularly in the aftermath of the COVID-19 pandemic, the consumables market is being stimulated by the increasing emphasis on antiseptic procedures and infection control. 

The demand for disposable medical supplies, including gloves, masks, and gowns, experienced a significant increase in 2023 and has remained elevated in 2024. For example, the global disposable glove market size was USD 9.2 billion in 2023 and was USD 10 billion in 2024. An additional trend is the increasing emphasis on minimally invasive surgical devices. These devices, which encompass robotic surgical systems, endoscopes, and laparoscopes, provide a variety of benefits, including a shorter recuperation time for patients, a reduced risk of complications, and cost savings. Technological advancements and an increase in surgical procedures are expected to propel the market for minimally invasive devices, which was valued at USD 45 billion in 2023 and was USD 50 billion by 2024.

Countries Contributing to Medical Devices & Consumables Market

United States (2024 Market Size: USD 195 billion)

According to cognitive market research, the U.S. medical devices market size was USD 180 billion in 2023 and was USD 195 billion by 2024, with a compound annual growth rate (CAGR) of 8.3%. By 2024, the consumables segment will increase in value to USD 24 billion, which includes items such as syringes, gloves, and catheters. In 2023, the segment was valued at USD 22 billion. Hospitals, outpatient facilities, and residential healthcare market are among the primary consumers of medical devices and consumables in the United States. The hospital sector is the largest, with over 60% of the utilization attributed to the high volume of surgeries and treatments performed. United States holds 34% of the medical devices and consumables market. This dominance is the result of a robust healthcare infrastructure and increased investment in research and development. The market has been further stimulated by the integration of cutting-edge technologies such as AI and IoT in medical devices, particularly in the areas of patient monitoring and diagnostics. Furthermore, the approval processes have been simplified by government initiatives and favorable regulatory frameworks, which have facilitated the faster entry of new products into the market.

Germany (2024 Market Size: USD 39 billion)

The Germany's medical devices market share is 7% of the total revenue generated and its market size is USD 39 billion in 2024, with a compound annual growth rate (CAGR) of 5.4%. In 2023 the Germany's medical devices market size was USD 37 billion. In 2023, the consumables market, which encompasses products such as surgical instruments and dressings, was valued at USD 4.5 billion. This will increase to USD 4.8 billion by 2024. In the elderly care sector, clinics and hospitals are the primary users, with hospitals accounting for 55% of the utilization due to the high volume of surgical procedures. The nation's robust industrial basis and emphasis on medical technology innovation are significant factors. Furthermore, Germany's high market value is a result of its substantial export market for medical devices. Technological innovations and elevated healthcare expenditures additionally bolster market expansion.

Japan (2024 Market Size: USD 35 billion)

According to cognitive market research, the Japan's medical devices market size was USD 33 billion in 2023. The Japan's medical devices market share is 6% of total revenue generated and its market size is USD 35 billion in 2024 with a compound annual growth rate (CAGR) of 6.1%. In 2023, the consumables segment, which encompasses items such as IV sets and syringes, was valued at USD 3.8 billion and will experience a growth rate of USD 4 billion in 2024. Hospitals and elderly care facilities are the primary users, with hospitals accounting for 60% of the utilization as a result of the high incidence of chronic diseases and the aging population. The market is driven by the country's commitment to continuous innovation in medical technology, particularly in imaging and diagnostics and high-quality healthcare. The Japan's medical devices and consumables market is further stimulated by government policies that encourage healthcare advancements and favorable reimbursement frameworks.

China (2024 Market Size: USD 33 billion)

The China's medical devices market size was USD 30 billion in 2023 and was USD 33 billion in 2024, with a compound annual growth rate (CAGR) of 10%. The consumables market, which encompasses products such as surgical instruments and syringes, was valued at USD 3.2 billion in 2023 and will increase to USD 3.6 billion in 2024. Hospitals and clinics are the primary users, with hospitals accounting for 65% of the utilization due to the substantial volume of medical procedures. China accounts for 5% of the global market.Key drivers include an expanding middle class, increasing healthcare expenditures, and rapid urbanization. Furthermore, the market expansion is substantially influenced by the government's initiatives to reform healthcare and its investments in the medical devices market. Technological advancements and domestic production are also essential.

France (2024 Market Size: 21.5 billion)

According to cognitive market research, the France's medical devices and consumables market share is 4% of the total revenue generated and its market size is USD 21.5 billion in 2024, with a compound annual growth rate (CAGR) of 7.5%. In 2023, the market size was USD 20 billion. The consumables segment, which encompasses items such as surgical bandages and dressings, was valued at USD 2.5 billion in 2023 and will increase to USD 2.7 billion by 2024. Hospitals, clinics, and home healthcare are the primary users, with hospitals accounting for 60% of the utilization. The market is driven by the country's substantial investment in medical technology and innovation, as well as its robust healthcare system. The market's development is also influenced by government initiatives and policies that promote healthcare advancements.

United Kingdom (2024 Market Size: USD 16 billion)

The medical devices market size in the United Kingdom is USD 16 billion, with a compound annual growth rate (CAGR) of 6.7%. In 2023, the U.K. medical devices market size USD 15 billion.The consumables segment, which encompasses items such as surgical instruments and catheters, was valued at USD 1.8 billion in 2023 and will increase to USD 2 billion in 2024. Hospitals and primary care facilities are the principal users, with hospitals accounting for 55% of the usage. United Kingdom holds 3% of the global market share. The market is driven by a strong emphasis on innovation, particularly in the areas of digital health technologies and diagnostics. Furthermore, the expansion of the market is significantly facilitated by government support and favorable regulatory environments.

Italy (2024 Market Size: USD 14 billion)

The Italian medical devices market share is 2.5% of the total revenue generated and its market size is USD 14 billion in 2024, with a compound annual growth rate (CAGR) of 7.7%. In 2023, the market size of medical devices in Italy was USD 13 billion. The consumables market, which encompasses products such as bandages and syringes, was valued at USD 1.6 billion in 2023 and will increase to USD 1.8 billion by 2024. Hospitals and clinics are the primary users, with hospitals accounting for 60% of the utilization. The market is experiencing development as a result of the country's robust healthcare system and its increasing investments in medical technology. Furthermore, Italy's high market value is a result of its substantial export market for medical devices.

Canada (2024 Market Size: USD 11 billion)

According to cognitive market research, the medical devices market size in Canada was USD 10 billion in 2023 and was USD 11 billion in 2024, with a compound annual growth rate (CAGR) of 8%. The consumables segment, which encompasses items such as surgical bandages and dressings, was valued at USD 1.2 billion in 2023 and will increase to USD 1.3 billion by 2024. Hospitals and outpatient facilities are the primary users, with hospitals accounting for 60% of the utilization. Canada holds 2% of the global market share. The market is driven by a strong emphasis on innovation, particularly in the areas of diagnostic imaging and patient monitoring. Furthermore, the expansion of the market is significantly facilitated by government support and favorable regulatory environments.

South Korea (2024 Market Size: USD 10 billion)

In 2023, the South Korea medical devices market share is 1.5% of the total revenue generated and its market size is USD 10 billion, with a compound annual growth rate (CAGR) of 8.9%. In 2023, the market size was USD 9 billion. The consumables market, which encompasses products such as bandages and syringes, was valued at USD 1.1 billion in 2023 and will increase to USD 1.2 billion in 2024. Hospitals and clinics are the primary users, with hospitals accounting for 65% of the utilization. The market is experiencing development as a result of the country's robust healthcare system and its increasing investments in medical technology. Furthermore, the high market value of South Korea is attributed to its substantial export market for medical devices. Technological innovations and elevated healthcare expenditures additionally bolster market expansion.

India (2024 Market Size: USD 9 billion)

The medical devices market size in India was USD 8 billion in 2023 and was USD 9 billion in 2024, with a compound annual growth rate (CAGR) of 12.5%. The consumables segment, which encompasses items such as IV settings and syringes, was valued at USD 950 million in 2023 and will increase to USD 1.1 billion by 2024. Hospitals and primary care facilities are the principal users, with hospitals accounting for 60% of the usage. India holds 1.5% of the global market share. Key drivers include an expanding middle class, increasing healthcare expenditures, and rapid urbanization. Furthermore, the market expansion is substantially influenced by the government's initiatives to reform healthcare and its investments in the medical devices market.

Key Players of Medical Devices & Consumables Market

Medtronic

Medtronic's revenue from the medical devices and consumables sector was USD 32 billion in 2023. It was USD 34 billion by 2024, a consistent increase that is driven by continuous innovation and market expansion. The company invested USD 2.7 billion in research and development in 2023 and will increase this amount to USD 2.9 billion in 2024. Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes comprise Medtronic's principal business segments. The Cardiac and Vascular segment, which predominantly deals with devices such as pacemakers, defibrillators, and stents, is a substantial contributor to their revenue. Furthermore, the Minimally Invasive Therapies Group, which encompasses surgical solutions and patient monitoring products, is crucial to their portfolio. Medtronic possess a significant portion of the global medical devices market, which is 7%. This dominance is due to the company's extensive product line, global presence, and ongoing advancements in medical technology. Medtronic's dedication to innovation, as demonstrated by its substantial R&D expenditure, establishes it as a pioneer in the introduction of groundbreaking medical devices and the preservation of a robust market presence.

Johnson & Johnson 

In 2023, Johnson & Johnson Medical Devices Companies, a subsidiary of Johnson & Johnson, reported revenue of USD 27 billion from the medical devices and consumables market. It was USD 29 billion in 2024. In 2023, the company's R&D expenditures in this market were USD 2.5 billion, and it will increase to USD 2.6 billion in 2024. Major business segments consist of Pharmaceuticals, Medical Devices, and Consumer Health. The Medical Devices segment, which includes surgery, orthopedics, interventional solutions, and vision, is a significant revenue generator. Surgical instruments, orthopedic implants, and interventional cardiovascular devices are among the most notable products. Johnson & Johnson possess 6% of the global market share in the medical devices and consumables market. This market share is bolstered by its extensive product portfolio, robust brand reputation, and substantial investments in innovation and development. The company's market position and capacity to address a wide range of healthcare requirements on a global scale are further enhanced by its strategic acquisitions and collaborations.

Siemens Healthineers

In 2023, Siemens Healthineers reported revenue of USD 20 billion from the medical devices and consumables marke and it was USD 21.5 billion by 2024. The company allocated USD 1.7 billion to research and development in 2023, with an increase to USD 1.8 billion in 2024. Imaging, Diagnostics, Advanced Therapies, and Varian (oncology solutions) comprise the organization's primary business segments. The Imaging segment, which includes products such as CT and MRI scanners, is particularly significant. Furthermore, the Diagnostics segment, which encompasses laboratory diagnostics and point-of-care testing, is a substantial revenue contributor. Siemens Healthineers holds 5% global market share in the medical devices and consumables market. The company's extensive global distribution network, strong R&D focus, and technological innovations all contribute to this share. The quality and reliability of Siemens Healthineers' advanced imaging and diagnostic solutions are widely acknowledged, which has contributed to the company's competitive advantage in the healthcare market.

GE Healthcare

In 2023, GE Healthcare generated an USD 18 billion in revenue from the medical devices and consumables market, and it will generate USD 19.5 billion in 2024. The company allocates USD 1.6 billion to research and development in 2023, with an increase to USD 1.7 billion in 2024. Imaging, Ultrasound, Pharmaceutical Diagnostics, and Life Care Solutions comprise the organization's principal business segments. The Imaging segment, which encompasses X-ray, MRI, and CT equipment, is a significant revenue generator. Life Care Solutions, which encompasses patient monitoring, anesthesia delivery, and neonatal care, is also noteworthy. In the medical devices and consumables market, GE Healthcare accounts for 4.5% global market share. This market position is bolstered by its substantial global presence, extensive product range, and strong emphasis on innovation. The company's market leadership is firmly established as a result of the comprehensive healthcare solutions and sophisticated imaging technologies that are employed to improve patient care and diagnostic accuracy.

Abbott Laboratories

In 2023, Abbott Laboratories' medical devices and consumables market generated an USD 15 billion in revenue, and was USD 16.5 billion by 2024. The company's R&D investment was USD 2.4 billion in 2023 and was USD 2.5 billion in 2024. Diagnostics, Medical Devices, Nutrition, and Established Pharmaceuticals comprise the organization's primary business segments. Cardiovascular devices, diabetes care, neuromodulation, and diagnostics comprise the Medical Devices segment, which generates substantial revenue. Notable products include the FreeStyle Libre (continuous glucose monitoring system) and the MitraClip (mitral valve repair unit). Abbott holds 4% of the global market share in the medical devices and consumables market. The company's extensive global reach, strong R&D focus, and innovative product offerings are the primary factors contributing to this market share. Abbott's effective and reliable cardiovascular devices and advanced diabetes care solutions are widely acknowledged, which has contributed to the company's sustained growth and strong market position.

The medical devices and consumables industry is growing rapidly, driven by aging populations, rising healthcare spending, and supportive regulations, boosting demand for implants, assistive tech, and home monitoring. Challenges include strict regulations, high R&D costs, and supply chain risks, but opportunities lie in emerging markets, health-tech partnerships, and eco-friendly devices. Key trends such as AI, precision medicine, and sustainable innovations are transforming healthcare and accelerating market growth.